CPRX vs. XPEL
Compare and contrast key facts about Catalyst Pharmaceuticals, Inc. (CPRX) and XPEL, Inc. (XPEL).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CPRX or XPEL.
Key characteristics
| CPRX | XPEL | |
|---|---|---|
| YTD Return | 35.63% | -15.28% |
| 1Y Return | 70.40% | -3.84% |
| 3Y Return (Ann) | 45.59% | -13.65% |
| 5Y Return (Ann) | 38.86% | 25.34% |
| 10Y Return (Ann) | 24.02% | 33.22% |
| Sharpe Ratio | 1.88 | 0.01 |
| Sortino Ratio | 2.56 | 0.57 |
| Omega Ratio | 1.33 | 1.10 |
| Calmar Ratio | 2.15 | 0.01 |
| Martin Ratio | 8.57 | 0.02 |
| Ulcer Index | 9.39% | 25.44% |
| Daily Std Dev | 42.75% | 73.25% |
| Max Drawdown | -94.25% | -99.77% |
| Current Drawdown | -4.72% | -55.01% |
Fundamentals
| CPRX | XPEL | |
|---|---|---|
| Market Cap | $2.75B | $1.24B |
| EPS | $1.18 | $1.75 |
| PE Ratio | 19.53 | 25.67 |
| Total Revenue (TTM) | $458.21M | $418.41M |
| Gross Profit (TTM) | $376.80M | $174.59M |
| EBITDA (TTM) | $202.05M | $66.67M |
Correlation
The correlation between CPRX and XPEL is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CPRX vs. XPEL - Performance Comparison
In the year-to-date period, CPRX achieves a 35.63% return, which is significantly higher than XPEL's -15.28% return. Over the past 10 years, CPRX has underperformed XPEL with an annualized return of 24.02%, while XPEL has yielded a comparatively higher 33.22% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CPRX vs. XPEL - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and XPEL, Inc. (XPEL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CPRX vs. XPEL - Dividend Comparison
Neither CPRX nor XPEL has paid dividends to shareholders.
Drawdowns
CPRX vs. XPEL - Drawdown Comparison
The maximum CPRX drawdown since its inception was -94.25%, smaller than the maximum XPEL drawdown of -99.77%. Use the drawdown chart below to compare losses from any high point for CPRX and XPEL. For additional features, visit the drawdowns tool.
Volatility
CPRX vs. XPEL - Volatility Comparison
The current volatility for Catalyst Pharmaceuticals, Inc. (CPRX) is 7.60%, while XPEL, Inc. (XPEL) has a volatility of 10.79%. This indicates that CPRX experiences smaller price fluctuations and is considered to be less risky than XPEL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CPRX vs. XPEL - Financials Comparison
This section allows you to compare key financial metrics between Catalyst Pharmaceuticals, Inc. and XPEL, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities